Literature DB >> 27428284

Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.

Ying-Wei Li1, Jin Guo1, He Shen1, Jun Li2, Nuo Yang1, Costa Frangou1, Kayla E Wilson1, Yinglong Zhang1,3, Ashley L Mussell1, Marius Sudol4, Amjad Farooq5, Jun Qu2, Jianmin Zhang1.   

Abstract

The Hippo signaling pathway regulates cellular proliferation and survival, thus exerting profound effects on normal cell fate and tumorigenesis. The pivotal effector of this pathway is YAP1, a transcriptional co-activator amplified in mouse and human cancers where it promotes epithelial-to-mesenchymal transition (EMT) and malignant transformation. The Hippo tumor suppressor pathway has been suggested to inhibit the YAP1 function through serine phosphorylation-induced cytoplasmic retention and degradation. Here we report that the tyrosine188 (Y188) site of YAP1 isoform with 2 WW domains (known as YAP1-2) plays an important role in YAP1-induced cellular transformation. IP-Mass Spectrometry analysis of YAP1 identified the phosphorylation of Y188 but not other tyrosine residues. In contrast to the aberrant 3D acinus formation observed in YAP1-WT transduced cells, overexpression of YAP1-Y188F (non-phosphorylated mimic) displayed normal 3D structures. In addition, knockdown of the endogenous YAP1 in MDA-MB231 breast cancer cells inhibited cell proliferation and migration, which were then successfully rescued by the exogenous YAP1-WT and YAP1-Y188E but not Y188F. Mechanistically, we also demonstrated that YAP1-Y188F had a higher affinity to the upstream negative regulator PTPN14 and was extensively localized in the cytoplasm. Since the Y188 is located in the conserved aromatic core of the WW domain of YAP1, our finding has a wide implication for WW domain signaling in general, where Y phosphorylation may act as a common positive regulator of the complex formation via WW domains. In summary, our results indicate that tyrosine 188 plays an important role in the YAP1-induced cellular transformation and its phosphorylation may intriguingly serve as a positive indicator of YAP1 activation.

Entities:  

Keywords:  Hippo pathway; YAP1; cellular transformation; tyrosine phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 27428284      PMCID: PMC5026814          DOI: 10.1080/15384101.2016.1207836

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  51 in total

Review 1.  Control of organ growth by patterning and hippo signaling in Drosophila.

Authors:  Kenneth D Irvine; Kieran F Harvey
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-06-01       Impact factor: 10.005

2.  YAP1 oncogene and its eight isoforms.

Authors:  M Sudol
Journal:  Oncogene       Date:  2012-11-19       Impact factor: 9.867

3.  Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product.

Authors:  M Sudol
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

4.  YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway.

Authors:  Yulei Zhao; Prem Khanal; Paul Savage; Yi-Min She; Terry D Cyr; Xiaolong Yang
Journal:  Cancer Res       Date:  2014-05-08       Impact factor: 12.701

5.  Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.

Authors:  Run Fan; Nam-Gyun Kim; Barry M Gumbiner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

6.  GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy.

Authors:  Yu Xue; Jian Ren; Xinjiao Gao; Changjiang Jin; Longping Wen; Xuebiao Yao
Journal:  Mol Cell Proteomics       Date:  2008-05-06       Impact factor: 5.911

Review 7.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Authors:  Fa-Xing Yu; Bin Zhao; Kun-Liang Guan
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

8.  YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14.

Authors:  J-M Huang; I Nagatomo; E Suzuki; T Mizuno; T Kumagai; A Berezov; H Zhang; B Karlan; M I Greene; Q Wang
Journal:  Oncogene       Date:  2012-06-11       Impact factor: 9.867

9.  Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.

Authors:  Nikola Vlahov; Simon Scrace; Manuel Sarmiento Soto; Anna M Grawenda; Leanne Bradley; Daniela Pankova; Angelos Papaspyropoulos; Karen S Yee; Francesca Buffa; Colin R Goding; Paul Timpson; Nicola Sibson; Eric O'Neill
Journal:  Curr Biol       Date:  2015-11-05       Impact factor: 10.834

10.  Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins.

Authors:  B V V G Reddy; Kenneth D Irvine
Journal:  Dev Cell       Date:  2013-03-11       Impact factor: 12.270

View more
  5 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

2.  NTRK1 is a positive regulator of YAP oncogenic function.

Authors:  Xinyuan Yang; He Shen; Brian Buckley; Yanmin Chen; Nuo Yang; Ashley L Mussell; Mikhail Chernov; Lester Kobzik; Costa Frangou; Su-Xia Han; Jianmin Zhang
Journal:  Oncogene       Date:  2018-12-12       Impact factor: 9.867

3.  The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis.

Authors:  Xiao Zhang; Yongxia Qiao; Qi Wu; Yan Chen; Shaowu Zou; Xiangfan Liu; Guoqing Zhu; Yinghui Zhao; Yuxin Chen; Yongchun Yu; Qiuhui Pan; Jiayi Wang; Fenyong Sun
Journal:  Nat Commun       Date:  2017-05-05       Impact factor: 14.919

4.  Reciprocal Feedback Loop of the MALAT1-MicroRNA-194-YAP1 Pathway Regulates Progression of Acute Pancreatitis.

Authors:  Lina Gu; Jingyao Liu; Dan Xu; Ying Lu
Journal:  Med Sci Monit       Date:  2019-09-13

5.  PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein.

Authors:  Amir Kedan; Nandini Verma; Ashish Saroha; Michal Shreberk-Shaked; Anna-Katharina Müller; Nishanth Ulhas Nair; Sima Lev
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.